Details of the NovAlix transaction - Narrative (Details) - Drug discovery collaboration transaction with NovAliX - EUR (€) |
Jun. 30, 2023 |
Dec. 31, 2024 |
|---|---|---|
| Ifrs Collaborative Arrangement And Arrangements Other Than Collaborative [Line Items] | ||
| Consideration | € 0 | |
| Term of collaboration agreement | 5 years | |
| Total commitment | € 73,800,000 | € 41,600,000 |
| Collaboration agreement advances to be released classed as other current assets | 2,700,000 | |
| Collaboration agreement advances to be released classed as non-current asset | 2,900,000 | |
| Upfront payment made. | € 8,300,000 | |
| Remaining part of upfront payment to be released - current | 2,200,000 | |
| Remaining part of upfront payment to be released - Noncurrent | € 2,600,000 |